Page 400 - Bloedstollig en bloedingsneiging

388 Bloedstolling en bloedingsneiging
696-701, met name p. 697.
xviii–36: J. Meijers, Bloedstollend - Rede, 18 december 2009 (Amsterdam: VossiusPers UvA, 2009), p. 10. xviii–37: H.R. Büller, Cl. Bethune, et al. [for the FXI-ASO TKA Investigators], ‘Factor XI antisense oligonucleo- tide for prevention of venous thrombosis’, New England journal of medicine 372 (2015), 232-40.
xviii–38: N. Mackman, ‘Triggers, targets and treatments for thrombosis’, Nature 451 (2008), 914-8.
xviii–39: B. Stein, V. Fuster, et al., ‘Platelet inhibitor agents in cardiovascular disease: An update’, Journal of the American College of Cardiology 14 (1989), 813-36; N. Mackman, ‘Triggers, targets and treatments for thrombosis’, Nature 451 (2008), 914-8.
xviii–40: D.D. Wagner, ‘The Weibel-Palade body is the perfect first aid kit after an insult to the vasculature’, Journal of thrombosis and haemostasis 10 (2012), 979-84.
xviii–41: Zie bijvoorbeeld G. van Dieijen, G. Tans, J. Rosing en H.C. Hemker, ‘The role of phospholipid and factor VIII in the activation of bovine factor X’, Journal of biological chemistry 256 (1981), 3433-41.
xviii–42: K. Mertens, The intrinsic activation of human blood coagulation factor X (Leiden: RUL, 1985). xviii–43: M.G. Rondaij, R. Bierings, A. Kragt, J.A. van Mourik en J. Voorberg, ‘Dynamics and plasticity of Weibel-Palade Bodies in endothelial cells’, Arteriosclerosis, thrombosis and vascular biology 26 (2006), 1002-7.
Hoofdstuk XIX
xix–1: Interview met Jan Rosing (september 2013).
xix–2: Coen Hemker in email aan de auteur (17 augustus 2014).
xix–3: L. Ernster [Royal Academy of Sciences], ‘Nobel Prize Chemistry 1978’, in: T. Frängsmyr (red.), Nobel lectures including presentation speeches and laureates’ biographies: Chemistry, 1971-1980 (Singapore: World Scientific Publishing, 1993), p. 290
xix–4: J. Rosing, ‘Teaching biochemistry at a medical faculty with a problem-based learning system’, Biochemical education 25 (2) (1997), 71-4.
xix–5: H.C. Hemker, ‘The initiation phase: Review of old clotting times’, Thrombosis & haemostasis 98 (2007), 20-3.
xix–6: D. Menache-Aronson, ‘Jean-Pierre Soulier, 1915-2003’, Journal of thrombosis and haemostasis 1 (2003), 1125-6.
xix–7: R.G. Macfarlane en R. Biggs, ‘A thrombin generation test: The application in haemophilia and thrombocyt- openia’, Journal of clinical pathology 6 (1953), 3-8, met name p. 3; W.R. Pitney en J.V. Dacie, ‘A simple method of studying the generation of thrombin in recalcified plasma: Application in the investigation of haemophilia’, Journal of clinical pathology 6 (1953), 9-14.
xix–8: H.C. Hemker, Een bloedstollende geschiedenis: Holstlezing - Uitgesproken 18 november 1999 aan de Technische Universiteit Eindhoven (Eindhoven: TU/e, 1999), p. 9.
xix–9: H.C. Hemker, ‘Recollections on thrombin generation’, Journal of thrombosis and haemostasis 6 (2007), 219-26, met name p. 222.
xix–10: Ibid., p. 221.
xix–11: Interview met Jan Rosing (september 2013).
xix–12: Interview met Theo Lindhout (januari 2014).
xix–13: H.C. Hemker, Een bloedstollende geschiedenis: Holstlezing - Uitgesproken 18 november 1999 aan de Technische Universiteit Eindhoven (Eindhoven: TU/e, 1999), p. 10.
xix–14: Ibid., p. 11.
xix–15: Ibid., p. 10.
xix–16: Zie voor de connectie van Utrecht met La Jolla, hoofdstuk IX.
xix–17: R.C. Rotteveel, K.J. Roozendaal, L. Eijsman en H.C. Hemker, ‘The influence of oral contraceptives on the time-integral of thrombin generation (Thrombin Potential)’, Thrombosis and haemostasis 70 (1993), 959-62. xix–18: J. Rosing en G. Tans, ‘Highlight main theme I: Acquired APC resistance, oral contraceptives and venous thrombosis’, (n.d.). Zie ook: J. Rosing, G. Tans, G.A.F. Nicolaes, M.C.L.G.D. Thomassen, R. van Oerle, P.M.E.N. van der Ploeg, P. Heijnen, K. Hamulyak en H.C. Hemker, ‘Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives’, British journal of haematology 97 (1997), 233-8; J. Rosing, H.C. Hemker en G. Tans, ‘Molecular biology and pathophysiology of APC resistance: Current insights and clinical implications’, Seminars in thrombosis and hemostasis 24 (1998), 329-35; J. Rosing en G. Tans, ‘Effects of oral contraceptives on hemostasis and thrombosis’, American journal of obstetrics and gynecology 180 (Suppl.) (1999), S375-82; J. Rosing, J. Curvers en G. Tans, ‘Oral contraceptives, thrombosis and haemostasis’, European journal of obstetrics & gynecology and reproductive biology 95 (2001) 193-7; S.N. Tchaikovski en J. Rosing, ‘Mechanisms of estrogen-induced venous thromboembolism’, Thrombosis research 126 (2010), 5-11.
xix–19: G.M. Willems, P.L.A. Giesen en W.T. Hermens, ‘Adsorption and conversion of prothrombin on a rotating disc’, Blood 82 (1993), 497-504.